Zydus Cadila unit gets USFDA nod for generic plaque psoriasis treatment drug
newsdepo.com
The company#39;s US-based subsidiary Zydus Pharmaceuticals (USA) Inc has received final approval from the US Food and Drug Administration (USFDA) to market Apremilast tablets in the strengths of 10 mg, 20 mg, 30 mg in the US market, Zydus Cadila said in a staZydus Cadila unit gets USFDA nod for generic plaque psoriasis treatment drug
The company#39;s US-based subsidiary Zydus Pharmaceuticals (USA) Inc has received final approval from the US Food and Drug Administration (USFDA) to market Apremilast tablets in the strengths of 10 mg, 20 mg, 30 mg in the US market, Zydus Cadila said in a statement. Read more